Gralise Starter Pack is a Kit in the Human Prescription Drug category. It is labeled and distributed by Assertio Therapeutics, Inc.. The primary component is .
Product ID | 13913-006_15b124c8-345a-3a45-2c20-fbe258fb82b3 |
NDC | 13913-006 |
Product Type | Human Prescription Drug |
Proprietary Name | Gralise Starter Pack |
Generic Name | Gabapentin |
Dosage Form | Kit |
Marketing Start Date | 2011-01-28 |
Marketing End Date | 2022-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA022544 |
Labeler Name | Assertio Therapeutics, Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Marketing Start Date | 2011-01-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022544 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-01-28 |
Marketing End Date | 2022-12-31 |
SPL SET ID: | 7d12b4e9-ed44-43c0-9e46-f6c195300f03 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
13913-006 | Gralise Starter Pack | Gralise Starter Pack |
0093-4443 | Gabapentin | Gabapentin |
0093-4444 | Gabapentin | Gabapentin |
0143-3991 | Gabapentin | Gabapentin |
0143-3993 | Gabapentin | Gabapentin |
0143-3994 | Gabapentin | Gabapentin |
0143-9992 | Gabapentin | Gabapentin |
0143-9993 | Gabapentin | Gabapentin |
0143-9994 | Gabapentin | Gabapentin |
0071-0401 | Neurontin | gabapentin |
0071-0513 | Neurontin | gabapentin |
0071-0803 | Neurontin | gabapentin |
0071-0805 | Neurontin | gabapentin |
0071-0806 | Neurontin | gabapentin |
0071-2012 | Neurontin | gabapentin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GRALISE 88511419 not registered Live/Pending |
Assertio Therapeutics, Inc. 2019-07-12 |
GRALISE 86982952 5312458 Live/Registered |
ASSERTIO THERAPEUTICS, INC. 2016-01-14 |
GRALISE 86875330 not registered Dead/Abandoned |
ASSERTIO THERAPEUTICS, INC. 2016-01-14 |
GRALISE 77934261 4132334 Live/Registered |
ASSERTIO THERAPEUTICS, INC. 2010-02-12 |